156 related articles for article (PubMed ID: 6225389)
1. Pharmacokinetics of cefoperazone in full-term and premature neonates.
Rosenfeld WN; Evans HE; Batheja R; Jhaveri RC; Vohra K; Khan AJ
Antimicrob Agents Chemother; 1983 Jun; 23(6):866-9. PubMed ID: 6225389
[TBL] [Abstract][Full Text] [Related]
2. Cefoperazone pharmacokinetics in preterm infants.
Bosso JA; Chan GM; Matsen JM
Antimicrob Agents Chemother; 1983 Mar; 23(3):413-5. PubMed ID: 6221693
[TBL] [Abstract][Full Text] [Related]
3. Cefoperazone pharmacokinetics in acute childhood meningitis.
Chartrand SA; Marks MI; Johnston JT; Frederick DF; Scribner RK
J Pediatr; 1983 Dec; 103(6):991-5. PubMed ID: 6644441
[TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical evaluation latamoxef in newborn and premature infants].
Toyonaga Y; Kurosu Y; Sugita M; Kitagawa M; Hori M
Jpn J Antibiot; 1983 Sep; 36(9):2322-35. PubMed ID: 6655851
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis.
Cable D; Overturf G; Edralin G
Antimicrob Agents Chemother; 1983 May; 23(5):688-91. PubMed ID: 6223578
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
Motohiro T; Sakata Y; Oda K; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Fujimoto T; Tominaga K
Jpn J Antibiot; 1989 May; 42(5):1102-24. PubMed ID: 2664254
[TBL] [Abstract][Full Text] [Related]
7. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
Neu HC
Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
[TBL] [Abstract][Full Text] [Related]
8. A preliminary pharmacokinetic study of ceftazidime in premature, new born and small infants.
Prinsloo JG; Delport SD; Moncrieff J; Paton AM
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():361-4. PubMed ID: 6352645
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Schaad UB; McCracken GH; Threlkeld N; Thomas ML
J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].
Fuji R; Hashira S; Tajima T; Meguro H; Abe T; Sakata H; Kakehashi H; Fujita K; Murono K; Kaeriyama M
Jpn J Antibiot; 1990 Mar; 43(3):543-62. PubMed ID: 2197468
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cefoperazone in newborn infants.
Philips JB; Braune K; Ravis W; Cassady G; Dillon H
Pediatr Pharmacol (New York); 1984; 4(3):193-7. PubMed ID: 6493842
[TBL] [Abstract][Full Text] [Related]
12. [Flomoxef in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on the intestinal bacterial flora].
Fujita K; Murono K; Saijyo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
Jpn J Antibiot; 1991 Nov; 44(11):1216-27. PubMed ID: 1784072
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics and clinical studies on flomoxef in neonates and premature infants. A study of flomoxef in the perinatal collaboration research group].
Fujii R; Fujita K; Murono K; Saijo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
Jpn J Antibiot; 1993 Jul; 46(7):518-38. PubMed ID: 8371489
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic and clinical studies on flomoxef in neonates and premature infants].
Akita H; Sato Y; Iwata S; Sunakawa K; Yokota T
Jpn J Antibiot; 1991 Nov; 44(11):1240-9. PubMed ID: 1784074
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group].
Fujii R; Okuno A; Fujita K; Kakuya F; Maruyama S; Sakata H; Inyaku F; Abe T; Hashira S; Nakazato Y; Sugiura M; Tajima T; Nagai S; Funamoto N; Sugimori S; Nishimura S; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Takeuchi Y; Kantake M; Sunakawa K; Yagisawa M
Jpn J Antibiot; 1996 Jul; 49(7):678-702. PubMed ID: 8828070
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
Nahata MC; Durrell DE; Barson WJ
Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of cefoperazone and cefamandole.
Srinivasan S; Francke EL; Neu HC
Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
Greenfield RA; Gerber AU; Craig WA
Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants].
Toyonaga Y; Sugita M; Hori M; Joh K
Jpn J Antibiot; 1988 Nov; 41(11):1671-91. PubMed ID: 3210301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
